All antihypertensive drugs lower (by definition) BP, and the main benefit based on a large number of randomized trials is due to lowering of BP per se and is largely independent of the drugs employed.

Systolic blood pressure kept under 130 reduces the risk of heart-related death by about 26% among people 80 or older, ...

A recent article suggests that increased efforts by clinicians to promote healthy sleep habits may prevent hypertension in ...

Scientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.

The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...

Mineralys Therapeutics’s oral hypertension therapy, lorundrostat, has met the primary endpoint in two pivotal studies, ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Among patients with isolated systolic hypertension and frailty, antihypertensive therapy is associated with improved outcomes.

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

The Calcium Channel Blockers Market was valued at US$ 14.5 Bn in 2022 and is projected to grow at a CAGR of 5.7% from 2023 to ...

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of ...